Listen to this podcast where we step into the new year and explore research insights and projections for the field in 2024 in neuroscience.
List view / Grid view
Podcasts brought to you in association with Molecular Devices
Listen to this podcast where we dive into genetic engineering, its role and relationship with allogeneic immunotherapy.
Tune into this podcast to understand why researchers are turning to 3D Organoids and how organoids can be made ready for screening.
Tune into this podcast to hear experts discussing the tumour microenvironment in immuno-oncology!
This episode defines allogeneic cell therapy as the administration of cells to a patient for therapeutic use, that were not initially taken from that patient.
Tune in to this episode to hear experts discussing the hot topic that is AI and how AI technology is used in drug discovery, looking specifically at how Biotechs & Pharma are trying to keep up with emerging technology.
Tune into this podcast to hear experts discussing the current landscape of adoptive cell therapies!
Tune into this podcast to hear experts discussing scaling up 3D organoids!
Tune into this podcast to hear experts discuss imaging and analysing data from organoids!
Tune into this podcast to hear experts discuss imaging and obtaining data from organoids!
Join our experts as they discuss factors causing variability issues in organoids and how to avoid them.
Episode 14 – Complex assays with Ian Shoemaker, Beckman Coulter Life Sciences & Dr Oksana Sirenko, Molecular Devices
Tune in to this podcast to hear experts discuss 3D cell models, organoids and the automation of complex cell assays.
Episode 13 – Multiplexing with Dr Luke Gammon, Queen Mary University & Dr David Pointu, Leica Microsystems
Join our experts as they discuss the advantages of multiplexed imaging for a wide range of research and how this technique will develop in the future.
Episode 12 – ELISA assays with Dr Ana Miletic and Anna Dey, Kyowa Kirin & Dr Cathy Olsen, Molecular Devices
In this episode, experts discuss how they use ELISA assays in their research as well as the specific benefits of this kind of immunoassay.
Join leading experts as they discuss the wide range of uses for CRISPR, including for therapeutics and biomanufacturing.